Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2016 /
'Helper' T Cells effective in therapy, and shows early clinical responses in patients with metastatic cancer

16th - 20th Apr 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.05.16
Views: 1886

Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA

Dr Yong-Chen William Lu speaks with ecancertv at AACR 2016 about a phase I study of using CD4 T cells in therapy.

Often described as 'helper T Cells', CD4 T cells used by Dr Lu helped safely target cancer cells in trial patients and stimulate anti-tumour responses.

He also introduces his ongoing work with MAGE-A3, a cancer gemini antigen that exists only in tumour cells and undifferentiated cells, as a promising target in further trials.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation